Write your message
   [Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 12, Issue 1 (Spring 2009) ::
EBNESINA 2009, 12(1): 41-49 Back to browse issues page
Meningococcal infection and its effective vaccines
K Abedini , M Darvishi, S Zareiy, M Samadpoor, A Eskandari
Abstract:   (3605 Views)
Neisseria meningitidis is a leading cause of bacterial meningitis and other invasive bacterial infections, both in the United States and worldwide. The role of the meningococcus as a cause of bacterial meningitis has become more important in recent years with the declines in meningitis caused by Haemophilus influenzae type b and Streptococcus pneumoniae because of the introduction of new conjugate vaccines, Listeria because of efforts to reduce the contamination of food with L. monocytogenes, and group B streptococcus because of the use of chemoprophylaxis during parturition in women. The development of a pneumococcal vaccine six decades ago demonstrated the feasibility of vaccine prevention of invasive encapsulated bacterial diseases. Purified polysaccharide vaccines for serogroups A and C N. meningitidis were developed several decades later. Early vaccines were poorly immunogenic apparently because the polysaccharides that were used were of low molecular weight, whereas vaccines made from polysaccharide with a molecular weight over 100,000 had excellent immunogenicity. Meningococcal conjugate vaccines, are typically T-cell dependent, which as regards of immunologic improvements over polysaccharide vaccines. The carrier proteins used for meningococcal conjugate vaccines have included tetanus toxoid protein, diphtheria toxoid, and diphtheria cross-reactive material (CRM)197. The immunogenicity of a variety of outer membrane protein- based serogroup B vaccines has been studied. In an evaluation of three doses of a Cuban B:4:P1.15 vaccine and a Norwegian B:15:P1.7,16 showed that more than two-thirds of children and adults had at least a fourfold rise in SBA, as did at least 90% of infants
Keywords: N. meningitides, Vaccine, Meningococcal infection
Full-Text [PDF 268 kb]   (2340 Downloads)    
Type of Study: Original |
Received: 2014/09/8 | Accepted: 2014/09/8 | Published: 2014/09/8
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abedini K, Darvishi M, Zareiy S, Samadpoor M, Eskandari A. Meningococcal infection and its effective vaccines. EBNESINA. 2009; 12 (1) :41-49
URL: http://ebnesina.ajaums.ac.ir/article-1-203-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 1 (Spring 2009) Back to browse issues page
ابن سینا EBNESINA
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4343